BridgeBio Oncology Therapeutics, Inc (BBOT)

Last Closing Price: 1.80 (2026-11-18)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

BridgeBio Oncology Therapeutics, Inc (BBOT) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-34.18M
Cost of Goods Sold
--
--
$37.49M
$-37.49M
$3.31M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-37.49M
$-37.30M
80.19M
80.19M
$-0.43
$-0.43
Balance Sheet Financials
$208.33M
$0.81M
$137.90M
$346.22M
$51.03M
--
$1.81M
$52.84M
$293.39M
$293.39M
$293.39M
80.23M
Cash Flow Statement Financials
$-108.64M
$-189.34M
$0.77M
$373.82M
$76.61M
$-297.21M
$15.84M
--
--
Fundamental Metrics & Ratios
4.08
--
--
--
--
--
--
--
--
--
--
$-108.73M
--
--
--
--
--
--
--
-11.65%
-11.65%
-9.87%
-11.65%
$3.66
$-1.36
$-1.35